Literature DB >> 26349425

[Strategies for antifungal treatment failure in intensive care units].

C Arens1, M Bernhard2, C Koch3, A Heininger4, D Störzinger5, T Hoppe-Tichy5, M Hecker6, B Grabein7, M A Weigand1, C Lichtenstern8.   

Abstract

Recent epidemiologic studies reveal both an increasing incidence and an escalation in resistance of invasive fungal infections in intensive care units. Primary therapy fails in 70 % of cases, depending on the underlying pathogens and diseases. The purpose of this review is to raise awareness for the topic of antifungal therapy failure, describe the clinical conditions in which it occurs, and suggest a possible algorithm for handling the situation of suspected primary therapy failure.

Entities:  

Keywords:  Algorithm; Aspergillosis; Candidiasis; Fungemia; Sepsis

Mesh：

Substances：

Year:  2015        PMID： 26349425     DOI： 10.1007/s00101-015-0072-0

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


  180 in total

Review 1.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; J Peter Donnelly; Paul E Verweij
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

2.  Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy.

Authors:  L Laatikainen; M Tuominen; K von Dickhoff
Journal:  Am J Ophthalmol       Date:  1992-02-15       Impact factor: 5.258

3.  Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Authors:  Brad Moriyama; Marisa Ditullio; Eleanor Wilson; Stacey A Henning; Scott R Penzak; Robert L Danner; Gennethel Pennick; Michael G Rinaldi; Adrian M Zelazny; Juan Gea-Banacloche; A John Barrett; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

4.  Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.

Authors:  David Goldblum; Kaspar Rohrer; Beatrice E Frueh; Regula Theurillat; Wolfgang Thormann; Stefan Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

Authors:  Georgios Chamilos; Edith M Marom; Russell E Lewis; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2005-05-24       Impact factor: 9.079

6.  Impact of therapeutic strategies on the prognosis of candidemia in the ICU.

Authors:  Mireia Puig-Asensio; Javier Pemán; Rafael Zaragoza; José Garnacho-Montero; Estrella Martín-Mazuelos; Manuel Cuenca-Estrella; Benito Almirante
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

7.  A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

Authors:  John H Rex; Peter G Pappas; Adolf W Karchmer; Jack Sobel; John E Edwards; Susan Hadley; Corstiaan Brass; Jose A Vazquez; Stanley W Chapman; Harold W Horowitz; Marcus Zervos; David McKinsey; Jeannette Lee; Timothy Babinchak; Robert W Bradsher; John D Cleary; David M Cohen; Larry Danziger; Mitchell Goldman; Jesse Goodman; Eileen Hilton; Newton E Hyslop; Daniel H Kett; Jon Lutz; Robert H Rubin; W Michael Scheld; Mindy Schuster; Bryan Simmons; David K Stein; Ronald G Washburn; Linda Mautner; Teng-Chiao Chu; Helene Panzer; Rebecca B Rosenstein; Jenia Booth
Journal:  Clin Infect Dis       Date:  2003-05-08       Impact factor: 9.079

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.

Authors:  Maiken Cavling Arendrup; Manuel Cuenca-Estrella; Cornelia Lass-Flörl; William W Hope
Journal:  Mycoses       Date:  2014-01-13       Impact factor: 4.377

10.  Effects of echinocandin preparations on adult rat ventricular cardiomyocytes. Preliminary results of an in vitro study.

Authors:  C Arens; F Uhle; M Wolff; R Röhrig; C Koch; A Schulte; S Weiterer; M Henrich; M A Weigand; K-D Schlüter; C Lichtenstern
Journal:  Anaesthesist       Date:  2014-02-07       Impact factor: 1.041
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.